| The therapeutic dilemma of hypertension in the elderly. | |
| | |
MedLine Citation:
|
PMID: 3071463 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There are good reasons to treat hypertension in the elderly. Elevated blood pressure at any age increases morbidity and mortality from cardiovascular disease. Treatment trials suggest that antihypertensive treatment in the elderly decreases strokes, may improve the cardiovascular morbidity, but does not prolong life. Consequently, elevated blood pressure in people over 65 years of age should be treated, but there is no justification for an overly aggressive approach. Knowledge of side effects of various drugs and appreciation of a patient's specific features permit individual 'tailoring' of the treatment and optimise the outcome. No present-day antihypertensive drugs are specific for the elderly. The drive to combat cardiovascular morbidity and mortality in the elderly continues. New drugs are under development and promise to further improve results. |
| | |
Authors:
|
S Julius |
Related Documents
:
|
342303 - Clinical trial of acebutolol (sectral) in hypertension. 3740673 - Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. ... 342303 - Clinical trial of acebutolol (sectral) in hypertension. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Review |
Journal Detail:
|
Title: Drugs Volume: 36 Suppl 1 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 1988 |
Date Detail:
|
Created Date: 1989-05-19 Completed Date: 1989-05-19 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 7-17 Citation Subset: IM |
Affiliation:
|
University of Michigan, Ann Arbor. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Aging / physiology Antihypertensive Agents / adverse effects, therapeutic use* Clinical Trials as Topic Humans Hypertension / drug therapy*, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ageing, serotonin and ketanserin.
Next Document: Attenuation of burn-induced changes in hemodynamics and glucose metabolism by the PAF antagonist SRI...